Software tools for structure based rational drug design

被引:17
|
作者
Zsoldos, Z
Szabo, I
Szabo, Z
Johnson, AP
机构
[1] SimBioSys Inc, Toronto, ON M9W 6V1, Canada
[2] Univ Leeds, ICAMS, Leeds LS2 9JT, W Yorkshire, England
来源
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM | 2003年 / 666卷
关键词
rational drug design; ligand docking; de novo design; VHTS; scoring function;
D O I
10.1016/j.theochem.2003.08.105
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Scientific advancements during the past two decades have altered the way pharmaceutical research produces new bio-active molecules. Traditional 'trial and error' drug discovery efforts are gradually being replaced by structure based rational drug design. A key technique is the use of methods including X-ray crystallography and NMR for the determination of the 3-dimensional structure of a target protein followed by various modelling techniques for the design of small molecule ligands that could interact with the target structure. The first generation of the software tools were limited to energy calculations and molecular dynamics simulations based on simple force field models. More automated methods, like flexible ligand docking and de novo ligand design programs have emerged in the 90s. However, many of these software systems relied on stochastic algorithms to perform the search, effectively performing a computerised 'trial and error' search. SimBioSys provides ligand design and docking tools that are systematic, exhaustive, rely on rational rules, heuristics and dynamic knowledge bases. The novel algorithms designed and optimised to solve the specific problems greatly outperform the general random methods. The presentation gives a brief overview of the efficient algorithms behind the SPROUT (de novo ligand design) and eHiTS (flexible ligand docking and virtual high throughput screening) software tools. Validation test results are presented to demonstrate the effectiveness of these tools for the solution of practical drug design problems. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:659 / 665
页数:7
相关论文
共 50 条
  • [41] Drug repositioning by structure-based virtual screening
    Ma, Dik-Lung
    Chan, Daniel Shiu-Hin
    Leung, Chung-Hang
    CHEMICAL SOCIETY REVIEWS, 2013, 42 (05) : 2130 - 2141
  • [42] Drug Discovery for Mycobacterium tuberculosis Using Structure-Based Computer-Aided Drug Design Approach
    Ejalonibu, Murtala A.
    Ogundare, Segun A.
    Elrashedy, Ahmed A.
    Ejalonibu, Morufat A.
    Lawal, Monsurat M.
    Mhlongo, Ndumiso N.
    Kumalo, Hezekiel M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [43] Privileged structures: A useful concept for the rational design of new lead drug candidates
    Duarte, Carolina D.
    Barreiro, Eliezer J.
    Fraga, Carlos A. M.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (11) : 1108 - 1119
  • [44] STRUCTURAL BIOLOGY AND DIABETES-MELLITUS - MOLECULAR PATHOGENESIS AND RATIONAL DRUG DESIGN
    BLUNDELL, T
    HUBBARD, R
    WEISS, MA
    DIABETOLOGIA, 1992, 35 : S69 - S76
  • [45] Rational Drug Design Approach of Receptor Tyrosine Kinase Type III Inhibitors
    Kim, Cheolhee
    Kim, Eunae
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (42) : 7623 - 7640
  • [46] From Laptop to Benchtop to Bedside: Structure-based Drug Design on Protein Targets
    Chen, Lu
    Morrow, John K.
    Tran, Hoang T.
    Phatak, Sharangdhar S.
    Du-Cuny, Lei
    Zhang, Shuxing
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (09) : 1217 - 1239
  • [47] Subtype Selectivity in Phosphodiesterase 4 (PDE4): A Bottleneck in Rational Drug Design
    Srivani, P.
    Usharani, D.
    Jemmis, Eluvathingal D.
    Sastry, G. Narahari
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (36) : 3854 - 3872
  • [48] Small Molecule Efflux Pump Inhibitors in Mycobacterium tuberculosis: A Rational Drug Design Perspective
    Kapp, Erika
    Malan, Sarel F.
    Joubert, Jacques
    Sampson, Samantha L.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2018, 18 (01) : 72 - 86
  • [49] Specific Noncovalent Interactions at Protein-Ligand Interface: Implications for Rational Drug Design
    Zhou, P.
    Huang, J.
    Tian, F.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (02) : 226 - 238
  • [50] COMPUTATIONAL TOOLS FOR RATIONAL PROTEIN ENGINEERING OF ALDOLASES
    Widmann, Michael
    Pleiss, Juergen
    Samland, Anne K.
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2012, 2 (03): : e201209016